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Chemical structures of the ligands in their completely deprotonated forms with numbering 
of the ring protons. 
 
 































































H NMR spectra of complex 1 and ligand picH in DMSO-d6 (solvent peaks: #). 
(1)   [M‒Cl‒COO]+calcd = 272.0013 [M‒Cl]
+
calcd = 315.9912
(2)              [M‒Cl‒COO]+calcd = 286.0170    [M‒Cl]
+
calcd = 330.0068
(3)                                                                 [M‒Cl‒COO]+calcd = 351.9098  [M‒Cl]
+
calcd = 395.8996
(4)                                       [M‒Cl‒COO]+calcd = 315.9912     [M‒Cl]
+
calcd = 359.9810
(5)                                       [M‒Cl‒COO]+calcd = 315.9912     [M‒Cl]
+
calcd = 359.9810























Figure S3. Packing arrangement showing the system of the hydrogen bonds in crystal 1. Details of 
hydrogen bond parameters are collected in Table S2. 
 
 
Figure S4. Packing arrangement showing the system of the hydrogen bonds in crystal 2∙H2O. Details of 




Figure S5. Packing arrangement showing the system of the hydrogen bonds in crystal 3. Details of 




Figure S6. Packing arrangement showing the system of the hydrogen bonds in crystal 4. Details of 







Figure S7. UV-vis spectra of 5-Br-picH recorded at various pH values (a), calculated individual 
absorption spectra of ligand species (b).  {c5-Br-pic = 115 µM; pH = 2 ‒ 11.5; T = 25 ˚C; I = 0.20 M 





H NMR spectra of [Ru(6-toluene)(Z)3] (Z = Cl
‒
/H2O) in aqueous solution in the presence 
of 0.20 M chloride ion at the indicated pH values in the regions of the toluene CH protons (left side) 















 (= [M2(OH)3]); #: solvent 

































































 Concentration distribution curves for [Ru(6-toluene)(Z)3] (where Z = H2O/Cl
‒
) in 
aqueous solution in the presence of 0.20 M chloride ions in the pH range from 2 up to 10 together with 
the 
1
H NMR peak integrals for the CH3 toluene protons of M, [M2(OH)2] and [M2(OH)3] species 




Figure S10. Time-dependence of UV-vis absorption spectra recorded for the [Ru(6-toluene)(H2O)3]
2+ 
‒ picH (1:1) system at pH = 2.79 in the presence of chloride ions. The inset shows the absorbance 






























































Figure S11. Absorbance values at 310 nm recorded for the [Ru(6-toluene)(H2O)3]
2+ ‒ picH (1:1) 
system after 1 h, 24 h and 48 h waiting time in the presence of chloride ions at pH = 0.85 -2.79 using 
individual samples. {cRu = cL = 102 M; T = 25 ˚C; I = 0.20 M (KCl); ℓ = 1.0 cm} 
 
 
Figure S12. Time-dependence of absorbance values at 308 nm recorded for the [Ru(6-
toluene)(H2O)3]
2+ ‒ 3-Me-picH (1:1) system at pH = 1.92 (×) and at 0.86 (▲) in the presence of 
chloride ions with the fitted kinetic curves (dashed lines). {cRu = cL = 123 M; T = 25 ˚C; I = 0.20 M 


























































   
Figure S13. UV-vis spectra recorded for the water/chlorido exchange process in the complex 1 at pH 
= 5.50. Inset shows measured (‒) and fitted absorbance values (dashed line) at 308 nm and at various 





Figure S14. Absorbance values recorded at 320 nm for the water/chlorido exchange process in the 
complex 2 at pH = 6.70 at variable ionic strength (■) and at a constant ionic strength of 0.30 M 
NaClO4/NaCl (▲) (a). Calculated molar absorbance spectra for the aqua (solid lines) and chlorido 
(dashed lines) complexes at variable (red) and constant ionic strength (black) (b). {cRu = cL = 0.08 mM; 





















































































H NMR spectra of 1, HSA and HSA:1 systems in PBS’ buffer at pH 7.4 in the regions of 
the ligand and toluene CH protons (a) and the CH3 toluene protons (b). {c1 = 1.0 or 0.5 mM; cHSA = 





UV-vis spectra recorded for the LMM fractions of the ultrafiltered samples of HSA–1 
(dashed lines) with the corresponding reference spectra of samples containing 1 (solid lines). 
{Original sample composition: HSA: 40 µM, or 0 M for the references; 1: 366 µM (blue); 203 µM 




HSA:1 = 1:0.5 
HSA:1 = 1:1
(a) (b)
























H NMR spectra of N-MeIm, the [Ru(6-toluene)Cl(μ-Cl)]2 ‒ N-MeIm (1:1) system and 
the precursor alone at pH 7.4 in PBS’. The framed details of spectra with dashed line indicate peaks 
belonging to the Ru(6-toluene) complexes formed with N-MeIm .{c = 1 mM; T = 25 ˚C; 10% D2O; 





H NMR spectra of N-MeIm, the 1 ‒ N-MeIm (1:1) system and 1 alone at pH 7.4 in PBS’. 
The framed details of spectra with dashed line indicate peaks belonging to the unbound N-MeIm and 
were used for the calculation of the integrals. {c = 1 mM; T = 25 ˚C; 10% D2O; *: DSS peaks; #: 



















Table S1. Crystal data and structure refinement for complexes 1-3 and 5 
Compound 1 2∙H2O 3 5 
Color/shape Orange/Prism Yellow/Prism Yellow/Prism Yellow/Prism 
Empirical formula C13H12ClNO2Ru C14H16ClNO3Ru C13H11ClNO2Ru C14H12ClNO4Ru 
Moiety formula [Ru(C13H12NO2)(Cl)] [Ru(C14H14NO2)(Cl)]∙H2O [Ru(C13H11NO2)(Cl)] [Ru(C14H12NO4)(Cl)] 
Formula weight (g/mol) 350.76 382.80 429.66 394.77 
Temperature (K) 103(2) 103(2) 293(2) 293(2) 
Radiation and wavelength l 
(Å) 
Mo-K, 0.71075 Mo-K, 0.71075 Mo-K, 0.71075 Mo-K, 0.71075 
Crystal system monoclinic monoclinic triclinic triclinic 
Space group P 21/n P 21 P-1 P-1 
Unit cell dimensions     
a (Å) 8.2995(3) 6.1442(6) 7.616(3) 7.6948(14) 
b (Å) 14.9714(5) 13.7320(14) 7.754(4) 9.6578(19) 
c (Å) 10.0795(4) 8.3347(10) 12.938(6) 11.251(2) 
(°) 90 90 81.590(10) 98.060(7) 
 (°)
 
94.1300(10) 91.468(3) 86.380(18) 106.159(7) 
(°) 90 90 61.66(4) 109.866(8) 
Volume (Å3) 1973.30(13) 702.99(13) 665.2(6) 729.3(2) 






















F(000) 696 384 416
 
392 
Crystal size (mm) 0.50 x 0.25 x 0.25 0.50 x 0.10 x 0.10 0.50 x 0.10 x 0.05 0.25 x 0.10 x 0.05 
Absorption correction numerical numerical numerical numerical 
Min. and max. transmission 0.5596 and 0.7490 0.6975 and 0.9496 0.5635 and 0.8517 0.861 and 0.962 
range for data collection (°) 3.073 27.448 3.317 25.331 3.011 26.372 2.977 27.420 
Index ranges -10  h  10;-19 k 19;-13  
l  13 
-7  h  7;-16 k 16;-10  
l  10 
-9  h  9;-9 k 9;-16  l  
16 
-9  h  9;-12 k 12;-14  l 
 14 Reflections collected 46142 10100 5157 6875 
SI-12 
 
Completeness to 2 0.999 0.998 0.990 0.997 
Independent reflections (Rint) 2849 (0.0332) 2564 (0.0838) 2671 (0.1239) 3290 (0.0960) 
Reflections I>2(I) 2817 2355 1654 1927 












full-matrix least-squares on 
F
2
 Data / restraints / parameters 2849 /0 /164 2564 /4 /190 2671 /0 /173 3290 /0 /192 
Goodness-of-fit on F
2
 1.255 1.071 1.084 1.039 
Final R indices [I>2(I)] R1, 
wR2 
0.0214, 0.0583 0.0442, 0.0810 0.0985, 0.2456 0.0939, 0.1435 
R indices (all data)  R1, wR2 0.0217, 0.0585 0.0503, 0.0852 0.1373, 0.3049 0.1685, 0.1678 
Max. and mean shift/esd 0.000;0.000 0.000;0.000 0.000;0.000 0.000;0.000 












Table S2. Intermolecular interactions in the crystal structures of complexes 1-3 and 5. 
 
D-H…A D…H (Å) H…A (Å)  D…A (Å) D-H…A (o) 
1 
O6-H6…Cl1i 0.95 2.69 3.557(2) 153 
C9-H9…O2ii 0.95 2.42 3.196(2) 138 
C12-H12…O1iii 0.95 2.38 3.022(2) 124 
2∙H2O 
O3-H3v…Cl1iv 0.84(6) 2.35(7) 3.182(10) 169(17) 
O3-H3w…O1v 0.84(6) 2.40(10) 3.047(12) 134(9) 
O3-H3w…O2v 0.84(6) 2.29(5) 3.120(12) 169(10) 
C2-H2…O2vi 0.95 2.31 3.246(17) 168 
C5-H5…O1vii 0.95 2.37 3.318(12) 179 
C6-H6…O3viii 0.95 2.48 3.244(14) 138 
C12-H12…Cl1vii 0.95 2.79 3.671(10) 155 
3 
C5-H5…O2ix 0.93 2.47 3.11(2) 125 
C7-H7c…O1 (intra) 0.96 2.46 3.092(18) 124 
C8-H8…O2ix 0.93 2.33 3.26(2) 177 
5 
O3-H3O3…O2x 0.82 1.76 2.570(10) 169 
C3-H3…O4xi 0.93 2.51 3.183(14) 130 
C5-H5…Cl1vii 0.93 2.83 3.466(15) 127 





























Table S3. In vitro antiproliferative and cytotoxic effects: IC50 values in μM in two human cancer cell 
lines (sensitive and multidrug resistant) and normal embryonic lung fibroblasts presented for the 
complexes 1-5, the corresponding free ligands, the precursor [Ru(η6-toluene)Cl(μ-Cl)]2 and cisplatin 
as well as the for comparison. 













1 >100 84.84 ± 4.79 >100 >100 >100 
2 >100 79.19 ± 6.71 >100 >100 >100 
3 >100 >100 >100 >100 >100 
4 >100 >100 >100 >100 >100 
5 >100 >100 >100 >100 >100 
picH >100 >100 >100 >100 >100 
3-Me-picH >100 >100 >100 >100 >100 
5-Br-picH >100 >100 >100 >100 >100 
2,4-dipicH2 >100 >100 >100 >100 >100 
2,5-dipicH2 >100 >100 >100 >100 >100 
Ru 
precursor  
>100 >100 >100 >100 >100 





Table S4. pKa of the complexes [ML(H2O)]
+
 in the absence of chloride ions, the estimated Cl
‒
/H2O 
exchange constants (logK’ (H2O/Cl
‒
) for the [ML(H2O)]
+
 + Cl
‒ ⇌ [ML(Cl)] + H2O equilibrium, 
estimated ratio of the chlorinated complex [ML(Cl)] at 100 and 4 mM  chloride ion concentrations, 
and representative IC50 values measured in human cancer cells for the complexes of [Ru(
6
-








pKa (0 M Cl
‒














































































Antiproliferative activity: 84.84 mM in Colo320.
 b
 Data taken from Ref. 23. 
c 
logK’ = 1.83 reported in Ref. 23 
determined by 
1
H NMR spectroscopy was revised and a new data was determined by UV-vis spectrophotometry. 
d
 Data taken from Ref. 27. 
e
 Data taken from Ref. 29. 
f
 Data taken from Ref. 56. 
 
